Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 33,520 shares at $16.46 ($552K) on 2023-06-26, disclosed to the SEC on 2023-06-27.
Open-market purchase of $552k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.46 | 16,760 | $276K | 50.0% |
| 2 | $16.46 | 16,760 | $276K | 50.0% |
| Total | $16.46 avg | 33,520 | $552K | 100% |
| Filing → |
| NVCT | BUY | 2025-06-24 | $45K | — | Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |